About CNSDose
CNSDose is a company based in Australia. It operates as a HealthTech and Direct-to-Consumer (D2C). CNSDose has completed 1 acquisition, including CNSDose. CNSDose offers products and services including CNSDose Test. CNSDose operates in a competitive market with competitors including Orchid, Immunosis, The Gene Council, Private Genetic Health and Genepath, among others.
- Headquarter Australia
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CNSDose
CNSDose offers a comprehensive portfolio of products and services, including CNSDose Test.
Genetic test for personalized mental health medication guidance.
Funding Insights of CNSDose
Detailed funding history for CNSDose
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CNSDose
CNSDose has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CNSDose.
Investment portfolio details for CNSDose
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmacogenomics tools for anti-depressant regimens are developed.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for CNSDose
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CNSDose
Detailed financials for CNSDose
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cnsdose Comparisons
Peer comparison for CNSDose
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CNSDose
CNSDose operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orchid, Immunosis, The Gene Council, Private Genetic Health and Genepath, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genetic screening services are provided for embryos and couples.
|
|
| Locked | Locked | Locked |
Developer of a diagnostic platform for diagnosing patients with immune dysfunctions
|
|
| Locked | Locked | Locked |
Offers private genetic testing and counselling for cancer risk, with online appointments and expert advice.
|
|
| Locked | Locked | Locked |
Provides genetic counselling, testing, and education for families with health conditions.
|
|
| Locked | Locked | Locked |
Provides targeted gene sequencing for newborn screening and health detection.
|
Detailed competitors of CNSDose
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cnsdose
Complete news archive for CNSDose
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CNSDose
CNSDose is headquartered in Australia.
Personalized genetic testing for mental health medication guidance is offered by CNSDose, a service under Incite Genomics. Focus is placed on analyzing 19 genes related to liver metabolism and blood-brain barrier transport to reduce trial-and-error prescribing. Solutions are provided for conditions like depression, anxiety, and ADHD, with actionable reports for clinicians and patients. The healthcare sector is primarily served, with an emphasis on pioneering neuroscience and medication avoidance alerts across psychiatry, cardiology, and other fields.
CNSDose's top competitors include Orchid, Immunosis and The Gene Council.
CNSDose offers CNSDose Test.
CNSDose has made 1 acquisition, including CNSDose.